Action BXP BEXIMCO PHARMACEUTICALS LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Beximco Pharmaceuticals Limited London S.E.

Actions

BXP

US0885792061

Marché Fermé - London S.E.
Autres places de cotation
 17:35:27 02/05/2024 		Varia. 5j. Varia. 1 janv.
36,5 GBX 0,00 % Graphique intraday de Beximco Pharmaceuticals Limited -1,35 % -12,05 %
30/04 RÉSULTATS ET TRANSACTIONS : Software Circle et Beximco annoncent une hausse de leur chiffre d'affaires AN
30/04 Beximco Pharmaceuticals Limited annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
EARNINGS AND TRADING: Software Circle & Beximco report higher revenue
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
Beximco names Iqbal Ahmed as managing director
Beximco Pharmaceuticals to strengthen portfolio as interim profit up
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 30, 2023
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Beximco MD steps down to join Bangladeshi cabinet
Beximco Pharmaceuticals Limited Announces Stepping Down of Mr. Nazmul Hassan as Member of the Board
Beximco Pharmaceuticals Limited Announces Stepping Down of Mr. Nazmul Hassan as Managing Director
Beximco Pharmaceuticals Posts Higher Fiscal Q1 Profit, Revenue
Beximco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023
Beximco boosts revenue in local currency but profit falls
Beximco Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Beximco Pharmaceuticals Limited Proposes Dividend for the Year Ended June 30, 2023
Beximco working to fix deficiencies at manufacturing plant
Beximco Pharmaceuticals to Tackle Ophthalmic Manufacturing Unit Deficiencies After Malta Medicines Authority Audit
EARNINGS UPDATES: HC Slingsby profit falls, East Imperial loss narrows
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
TRADING UPDATES: Ferro-Alloy eyes revenue to drop below market view
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BXPHARMA
  4. Action BXP
  5. Actualités Beximco Pharmaceuticals Limited
  6. Autres langues